… The objective of this study was to describe an innovative service and evaluate the safety
of administering REGEN-COV, a monoclonal antibody combination of casirivimab and …

… antibody products that targeted the virus, developed as either monotherapy or a combination
of anti-SARS-CoV-… and safety of REGEN-COV to treat and prevent SARS-CoV-2 infection in …

… -2 variants of concern (VOC) in our study, multiple analyses have shown that the combination
of antibodies in REGEN-COV retains potency against major circulating VOCs, including …

… On 30 th July 2021, the FDA updated its EUA for the REGEN-COV monoclonal antibody ‘cocktail,’
with combined subcutaneous administration, for emergency use as post-exposure …

… We report the use of REGEN-Cov in preexposition prevention in KTRs. … before each
administration of REGEN-Cov. Anti-S antibodies were also measured before each treatment. …

… respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein, … the antibody titers among
patients who received REGN-COV … Subcutaneous REGEN-COV was also reported to prevent …

… of SARS-CoV-2. The combination retains activity against the Delta variant of the virus.2 …
FDA has authorized the monoclonal antibodies casirivimab and imdevimab (REGEN-COV) to be …

… Thirteen months prior to writing he received two of five cycles of G-benda, a combination of
… Anti-SARS-CoV-2 vaccine was administered in the window where REGEN-COV antibody …

… the SARS-CoV-2 spike protein receptor–binding domain and block virus entry. The 2-antibody
combination reduces the risk of emergence of treatment-induced SARS-CoV-2 variants …

… Few studies have investigated the use of this novel monoclonal antibody combination in the
… there was widespread access to the monoclonal antibodies at our institution, whereas the …